Plain-English translation of NCT07493421 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a combined approach for pancreatic cancer that has spread to the lining of your abdomen. The treatment involves surgery to remove your pancreatic tumor and visible cancer spots in your belly, followed by heated chemotherapy (Cisplatin and Paclitaxel) delivered directly into the abdominal cavity during the operation. The goal is to learn whether this intensive combination approach is safe, manageable, and improves how long patients survive.
Pancreatic cancer that spreads to the abdominal lining is very difficult to treat with standard chemotherapy alone. This trial exists to find out whether adding heated chemotherapy during surgery—which delivers the medication directly where the cancer is—might help people live longer and have better outcomes than current treatments.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will have already completed at least 6 months of chemotherapy to prepare your body. You will then undergo one major surgical procedure where surgeons remove your pancreas and any visible cancer spots in your abdomen, and deliver heated chemotherapy directly into your belly cavity for 90 minutes. After surgery, you will have follow-up visits to check how you're healing, monitor for any complications, and track how long you survive without the cancer coming back. The trial will follow you for at least 12 months to measure how the treatment affects your quality of life.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
China
Portugal